evolutionary information to predict placental enhancers. The trained classifiers accurately distinguish 23 enhancers from the genomic background and placental enhancers from enhancers active in other tissues. 24 Genomic features collected from tissues and cell lines involved in pregnancy are the most predictive of 25 placental regulatory activity. Applying the classifiers genome-wide enabled us to create a map of 33,010 26 predicted placental enhancers, including 4,562 high-confidence enhancer predictions. The genome-wide 27 placental enhancers are significantly enriched nearby genes associated with placental development and 28 birth disorders and for SNPs associated with gestational age. These genome-wide predicted placental 29 enhancers provide candidate regions for further testing in vitro, will assist in guiding future studies of 30 genetic associations with pregnancy phenotypes, and aid interpretation of potential mechanisms of action 31 for variants found through genetic studies. 32 33 34
The placenta is a complex temporary organ, essential for successful pregnancy. The placenta performs 36 many vital functions including transfer of nutrients to the developing fetus and protection against 37 infectious agents [1]. Placental dysfunction has been connected to pregnancy complications, such as 38 preeclampsia and preterm birth (PTB) [2] [3] [4] [5] . PTB and preeclampsia both have environmental risk factors 39 as well as a genetic component that is not well understood. Family and pedigree studies of PTB and 40 preeclampsia suggest strong genetic components, but heritability estimates for both vary considerably 41 [5, 6] , and genetic associations found through genome-wide association studies (GWAS) of these and
We trained our classifiers using enhancers defined by cap analysis of gene expression (CAGE) 78 from the FANTOM5 Transcribed Enhancer Atlas [20] . Analyzing 411 different tissues and cell lines, they 79 identified 38,538 robust human enhancers, of which 748 were active in the human placenta. We 80 characterized each enhancer by its DNA sequence properties, evolutionary conservation, and chromatin 81 state. Each region's DNA sequence composition was quantified by counting the occurrence of all five-82 nucleotide-long (5-mer) DNA sequences within the region. Evolutionary conservation was quantified 83 using mammalian conserved elements from phastCons [21] . Finally, we used functional genomics data 84 from the Roadmap Epigenomics Project [22] , including histone modifications and DNaseI 85 hypersensitivity data from hundreds of cellular contexts, to quantify the chromatin state of the region. 86 (See the Methods for a complete description of the features.). 87
Then, using these features, we trained a multi-kernel support vector machine (SVM) classifier-88 with one kernel for each of the three data types-to distinguish robust enhancers from random, length-89 matched non-enhancer regions from the genomic background (Fig 1; Step 1). For Step 2, we trained a 90 placental enhancer classifier using the 748 known placental enhancers as positives and a random subset of 91 2,000 robust non-placental enhancers as the negatives (Fig 1) . 92 93
Fig 1. Schematic of the placental enhancer prediction pipeline. First, we associated known enhancers 94 from diverse tissues (+) and non-enhancer regions from the genomic background (-) with a range of 95 informative features including their DNA sequence patterns, functional genomics data, and evolutionary 96 conservation across species. Second, we trained a multi-kernel support vector machine to distinguish the 97 enhancers from regions without enhancer activity using the associated features. We evaluated the 98 performance of trained classifiers using 10-fold cross validation. Finally, we applied a classifier trained to 99 distinguish enhancers from non-enhancers to all sequences in the human genome (Step 1). Then we 100 applied a second classifier trained to distinguish placental enhancers from enhancers active in other 101 tissues (
Step 2). This produced an accurate set of genome-wide placental enhancer predictions. 102 103
Accurate prediction of known placental enhancers 104
To assess the performance of our trained classifiers, we used 10-fold cross validation to compute average 105 receiver operating characteristic (ROC) curve and precision-recall (PR) curves. In 10-fold cross validation, 106 ten models are trained using a different 90% of the positive and negative training regions, and then each 107 model is evaluated on remaining 10% of the regions. We quantified our method's overall performance by 108 the average area under the curve (AUC) over the 10 runs. 109
The trained
Step 1 classifier performs very well at identifying FANTOM enhancers from 110 genomic background (Fig 2A; To evaluate the relevance of our high-confidence predicted placental enhancers to placental biology and 169 pregnancy, we examined nearby genes in the context of known gene annotations. Using the functional 170 enrichment analysis tool GREAT [23], we mapped each region to putative gene targets and then tested for 171 the enrichment of relevant Gene Ontology (GO) functional annotations. We found significant enrichment 172 for many relevant terms such as "placenta development" and "decreased placental labyrinth size" 173 (selected terms: To assess the biological importance of our high-confidence placental enhancers, we tested for enrichment 182 of regions associated with gestational age and preterm birth in a recent genome-wide association study 183 (GWAS) [9] . Forty-three of our predicted enhancers overlapped 12 out of 14 GWAS regions. To 184
interpret this, we compared the observed overlap to the number of overlaps found for 10,000 randomly 185 generated sets of genomic regions length-and chromosome-matched to our predictions and excluding 186 genomic gaps. Our putative enhancers were significantly enriched for relevant GWAS catalogued regions 187 associated with preterm birth and gestational age (P < 0.0001) with a calculated fold enrichment of 2.69 188 (relative to the mean of the randomized sets). 189
To compare the high-confidence placental enhancer set to the candidate placental enhancer set, 190
we tested the enrichment for specific functions near the candidate regions using GREAT and for overlap 191 with the pregnancy-related GWAS regions. We found similar placenta-related GO terms enriched near the 192 larger candidate placental enhancer set, for example: with GO terms such as "placenta development" (P =  193 3.80e-147) and "embryonic placenta development" (P = 3.82e-99 on clustering of TF binding sites (TFBS) in the mouse genome. We will refer to these putative enhancers 203
as "TFBS clusters." 204
We calculated the overlap between the TFBS clusters that mapped to human genome and did not 205 overlap exons or a 5kb region upstream of TSSs (1,044 TFBS clusters) and our high-confidence placental 206 enhancers. We found 82 elements (20,154 bp) overlapped between the two sets. Because the biological 207 information used to define enhancers differed between the sets, it is not surprising that our predictions and 208 the TFBS clusters identify largely distinct regions of the genome. 209
To evaluate the functional relevance of the TFBS clusters, we tested for enriched relevant 210 functions using GREAT and for enrichment in overlap with preterm birth and gestational age GWAS 211 regions. We examined the GO biological process terms "placenta development" and "embryonic placental 212 development" and both were comparably enriched among genes near the TFBS clusters (P = 2.95e-15 213
and P = 2.33e-17, respectively) as among our predicted enhancers. The results were similar for 214 enrichment for pregnancy-related GWAS regions. While 43 of our placental enhancers fell within a 215 GWAS region associated with preterm birth and gestational age with a calculated fold enrichment of 2.69 216 (P < 0.0001), the TFBS clusters overlapped 13 elements had a fold enrichment of 3.07 (P < 0.0006). 217
Overall Using an established machine learning framework, we identified 4,562 high-confidence placental 245 enhancers, as well as an expanded set of 33,010 candidate placental enhancers. These putative regulatory 246 regions are enriched near genes relevant to pregnancy, are enriched for overlap with variants associated 247 with diseases of pregnancy, and have similar transposable element profiles as validated enhancers. In 248 addition, the predicted enhancers significantly expand previously published sets of placental enhancers, 249 and thus provide greater power to interpret genetic associations with diseases influenced by the placenta. 250
For example, the fact that 12 out of 14 regions associated pregnancy complications in a recent GWAS are 251 in high linkage disequilibrium with a predicted enhancer underscores the utility of these genome-wide 252 enhancer maps. These candidates suggest targeted regions for testing when seeking the causal variants in 253 these regions and dissecting how they influence pregnancy. More accurate interpretation of these and 254 future GWAS hits is necessary for understanding the complex biology of pregnancy and eventually 255 improving the identification and prevention of disorders such as preterm birth. To facilitate the use of our 256 enhancer maps, they are now integrated into the GEneSTATION web platform for studying pregnancy 257 and preterm birth [19] . 258
Our predicted enhancer maps can be improved in several dimensions. First, they are undoubtedly 259 incomplete. Enhancer activity is highly context and stimulus dependent. Due to the paucity of training 260 data from diverse contexts, we have focused on identifying a set of candidate regions that have hallmarks 261 of potential regulatory activity in the placenta broadly without making specific contextual predictions. 262 Furthermore, the patterns learned by our machine learning classifier generalize existing patterns in the 263 evolution, sequence, and functional genomics of known placental enhancers, but are constrained by what 264 is currently known. Finally, there is heterogeneity in the cellular makeup of the placenta and existing data 265 do not enable cell-specific predictions. As more enhancer data become available from relevant cellular 266 contexts, we will continue to refine our predictions and integrate them with other annotations. 267
While the costs and technical difficulties of agnostically identifying enhancers are decreasing, 268 many tissues and cell types remain difficult to assay due to biological constraints and ethical 269 considerations. These challenges are compounded for tissues like the placenta that are rapidly evolving 270 between species, limiting the utility of information garnered through the study of model organisms. The negative set consisted of a random subset of 2,000 robust human enhancers, excluding placental 296 enhancers. All analyses in this paper were performed in reference to the UCSC Genome Browser 297
February 2009 assembly of the human genome (GRCh37/hg19). Any dataset not in this build was 298 mapped over to hg19 coordinates using the liftOver tool from the UCSC Kent tools with default 299 parameters [29] . 300 301 Feature data. Three types of data were used as features in the MKL algorithm: functional genomics, 302 evolutionary conservation, and DNA sequence motifs. Each type of data was assigned to its own kernel. 303
Following the approach used in previous applications of EnhancerFinder [16] , we used linear kernels, 304 consisting of computed dot products of feature vectors, for the functional genomics and evolutionary 305 conservation data. For the DNA sequence-based features we used a 5-spectrum kernel. The MKL 306 algorithm combines the three kernels by learning weights to assign to each kernel from the training set 307 [16] . 308
For the functional genomics kernel, we obtained 980 histone modification datasets (H3K27ac,  309 H3K4me1, H3K4me4, etc.) and 39 DNase datasets from 128 cellular contexts in the Human Epigenome 
Analysis of genome-wide placental enhancer predictions 360
Gene ontology annotation enrichment. To identify the functional annotations, phenotypes, and pathways 361 enriched among genes nearby the predicted placental enhancers, we used GREAT with the default 362 settings. GREAT is a web tool that takes a set of genomic regions and associates them with their putative 363 target genes and target gene annotations [23] . GREAT calculates the enrichment of annotations within the 364 input regions and returns the terms that are significantly enriched near the input regions. We submitted 365 our candidate placental enhancer set as well as our high confidence placental enhancer set to GREAT, 366 using the default entire human genome as the background. 367 368 Enrichment for regions relevant to pregnancy. We calculated the enrichment for GWAS SNPs in our 369 candidate placental enhancer set and high-confidence placental enhancer set. We obtained 14 preterm 370 birth and gestational age GWAS regions (omitting 3 regions on the X chromosome) from a recent GWAS 371 [9] . For each set of enrichment analyses, we generated 10,000 sets of random genomic regions that were 372 matched to the predicted enhancer set based on the length and chromosome distribution. Then, we 373 computed the overlap of each of the 10,000 random region sets with each set of regions of interest. 374 Enrichment was calculated by dividing the overlap of our predicted set with the mean overlap of the 375 10,000 randomly generated sets, and an empirical p-value was obtained by counting the number of 376 random sets for which as much or more overlap with the regions of interest is observed. 377 378 Comparison to previous placental enhancer predictions. We downloaded a set of 2,216 placental 379 enhancers defined using transcription factor binding site (TFBS) clusters related to placental function 380 from supplementary material of Tuteja et. al [17] . Of the 2,216 TFBS clusters whose build was of the 381 UCSC Genome Browser July 2007 assembly of the mouse genome (NCBI37/mm9), 2,207 TFBS clusters 382 mapped into hg19 using liftOver [29] . From these TFBS clusters, we generated a subset of 1,044 regions 383 by filtering out regions overlapping exons and regions within 5 kb of a transcription start site (TSS). The 384 motivation for generating a smaller subset of TFBS clusters comes from our concern that predicted 385 placental enhancers defined by TFBSs nearby TSSs may have an increased chance of being associated 386 with promoters rather than enhancers. All enrichment tests were calculated on both the larger and smaller 387 subset of TFBS clusters. Both sets of TFBS clusters had comparable enrichments. We report them for the 388 smaller set that is more comparable to our enhancer sets here. Dfam provided multiple clades, the clade of the most recent common ancestor was designated as the 393 origin. We collapsed all TEs originating in the last common ancestor of amniota or before into one 394 category. 395
For both the FANTOM5 placental enhancers and the high-confidence predicted placental 396 enhancers, we used shuffleBed [28] to shuffle enhancer regions around the genome. We constrained the 397 shuffled regions to the chromosome of the corresponding observed region and did not allow shuffled 398 regions overlap one another, gaps in the genome assembly, or ENCODE blacklist regions [34] . For the 399 FANTOM5 enhancers, we created 10,000 sets of shuffled regions. For the predicted enhancers, we 400 created 1,000 sets of shuffled regions separately for the high-confidence and candidate sets. We 401 calculated the permutation-based p-value for each lineage of origin for all TEs by calculating the number 402 of permuted sets that overlapped more or the same amount of TEs appearing on a given lineage. Tests 403 were only performed if at least 10 enhancers overlapped a TE of the given lineage. 404
406
Predicted enhancers of any specificity 400bp 2. Train and evaluate classifier to distinguish enhancers and non-enhancers based on genomic features
Trained enhancer classifier
Step 1: genome-wide enhancer prediction
Machine learning algorithm
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